OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Release Date
2023
(3)
2021
(3)
2025
(2)
2020
(2)
2019
(2)
2014
(2)
2011
(2)
2024
(1)
2016
(1)
2015
(1)
2012
(1)
2008
(1)
2007
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.
Not available
S-EPMC7213785
|
biostudies-literature
Cite
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Not available
S-EPMC5019421
|
biostudies-literature
Cite
Learning from Each Other: A Multisite Collaborative to Reduce Electrolyte Testing.
Not available
S-EPMC7591129
|
biostudies-literature
Cite
A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Not available
S-EPMC2581430
|
biostudies-literature
Cite
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
Not available
S-EPMC3675703
|
biostudies-literature
Cite
Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Not available
S-EPMC3025409
|
biostudies-literature
Cite
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
Not available
S-EPMC7857687
|
biostudies-literature
Cite
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
Not available
S-EPMC1705822
|
biostudies-literature
Cite
Genome scans of facial features in East Africans and cross-population comparisons reveal novel associations.
Not available
S-EPMC8375984
|
biostudies-literature
Cite
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Not available
S-EPMC9992261
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets